![](/img/cover-not-exists.png)
Three concerns with regards to the utilization of COX-2 inhibitor (celecoxib) in combination with standard chemoradiotherapy for nasopharyngeal carcinoma
Revannasiddaiah, Swaroop, Gupta, Manoj, Seam, Rajeev, Rastogi, MadhupVolume:
8
Year:
2012
Language:
english
Journal:
Journal of Cancer Research and Therapeutics
DOI:
10.4103/0973-1482.103540
File:
PDF, 270 KB
english, 2012